Breast Cancer Clinical Trial
Official title:
Decision-Making About Breast Reconstruction After Mastectomy Among Ethnic Minority Women: An Exploratory Study of Qualitative Themes
RATIONALE: Learning about the reasons for choosing to have, or not to have, breast
reconstruction after mastectomy for breast cancer may help doctors understand why black or
Latina women may or may not undergo breast reconstruction.
PURPOSE: This clinical trial is studying factors affecting decisions about breast
reconstruction after mastectomy in black and Latina women.
OBJECTIVES:
- Interview black and Latina women about their reasons for choosing to have, or not to
have, breast reconstruction after mastectomy for breast cancer.
- Describe the context in which black and Latina women make decisions about breast
reconstruction.
- Explore similarities and differences in factors affecting decision-making among black
and Latina women.
- Identify factors that contribute to the low utilization of breast reconstruction among
ethnic minority women.
OUTLINE: This is a multicenter study.
Patients undergo a 1-hour interview to evaluate their rationale for choosing to have, or not
to have, breast reconstruction after mastectomy. Interviews are conducted by a woman of the
same ethnic background as the patient. Key factors influencing a patient's decision to
consider having breast reconstruction are explored during the interview, including
availability of educational materials on breast reconstruction and the adequacy of this
information. Patients are asked to examine personal factors influencing their decision, such
as feelings about living with or without a reconstructed breast; concerns about
reconstructive surgery and its risks; potential complications; and impact of reconstructive
surgery on sexuality and body image. Social and cultural factors are also evaluated,
including influence of family and friends; degree of support for the patient's decision to
have surgery; racial or ethnic differences in patient's preferences; and cultural values.
Access-related factors, such as financial cost, insurance availability, or physician
referral practices, are also explored.
At the end of the interview, patients may be referred to Memorial Sloan-Kettering Cancer
Center or Ralph Lauren Center for Cancer Care and Prevention for oncologic surveillance or
for additional information on breast reconstruction. Patients may also be contacted after
the interview to answer follow-up questions, to clarify topics previously discussed, or to
provide further input or feedback on preliminary study findings.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |